Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jan 25 | RNA Avidity Biosciences | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 50,000 |
6 Jan 25 | RNA Avidity Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 31.42 | 50,000 | 1.57 mm | 50,000 |
1 Aug 24 | RNA Avidity Biosciences | Common Stock | Grant | Acquire A | No | No | 0 | 25,000 | 0.00 | 25,000 |
1 Aug 24 | RNA Avidity Biosciences | Stock Option Common Stock | Grant | Acquire A | No | No | 44.57 | 160,000 | 7.13 mm | 160,000 |
23 Jan 24 | MRTX Mirati Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 71,660 | 0.00 | 0 |
23 Jan 24 | MRTX Mirati Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 675 | 0.00 | 71,660 |
23 Jan 24 | MRTX Mirati Therapeutics | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 45.88 | 83,525 | 3.83 mm | 0 |
9 Aug 23 | MRTX Mirati Therapeutics | Common Stock | Grant | Acquire A | No | No | 37 | 22,297 | 824.99 k | 71,660 |